Table 2.
Patient characteristics in non-ACLD and ACLD patients.
| No statin despite indication | On statin therapy | No indication for statin | p-value | |
|---|---|---|---|---|
| non-ACLD | ||||
| # of patients | 55 | 106 | 577 | |
| Age [years] | 55.4 (17.4) | 58.0 (14.6) | 46.0 (20.68) | <0.001 |
| CAP [dB/m] | 252 (98) | 274.5 (80.3) | 242 (87) | <0.001 |
| BMI [kg/m²] | 26.2 (8.4) | 27.0 (8.1) | 25.2 (6.0) | 0.003 |
| Male sex (%) | 29 (52.7%) | 58 (54.7%) | 309 (53.6%) | 0.969 |
| Arterial hypertension (%) | 30 (54.5%) | 77 (72.6%) | 116 (20.1%) | <0.001 |
| NIDDM (%) | 24 (43.6%) | 33 (31.1%) | 11 (1.9%) | <0.001 |
| IDDM (%) | 3 (5.5%) | 6 (5.7%) | 12 (2.1%) | |
| (N)AFLD | 23 (41.8%) | 55 (51.9%) | 181 (31.4%) | <0.001 |
| Cholestatic LD | 3 (5.5%) | 8 (7.5%) | 13 (2.3%) | |
| Hepatitis C | 16 (29.1%) | 20 (18.9%) | 199 (34.5%) | |
| Hepatitis B | 3 (5.5%) | 4 (3.8%) | 31 (5.4%) | |
| Other LD | 10 (18.2%) | 19 (17.9%) | 153 (26.5%) | |
| ACLD | ||||
| # of patients | 67 | 72 | 388 | |
| Age [years] | 60.4 (15.0) | 60.8 (10.6) | 54.3 (14.7) | <0.001 |
| CAP [dB/m] | 290 (85) | 299 (130) | 247 (96) | <0.001 |
| BMI [kg/m²] | 29.7 (5.8) | 28.4 (7.9) | 26.4 (6.5) | <0.001 |
| Male sex (%) | 43 (64.2%) | 50 (69.4%) | 249 (64.2%) | 0.685 |
| Arterial hypertension (%) | 42 (62.7%) | 49 (68.1%) | 100 (25.8%) | <0.001 |
| NIDDM (%) | 39 (58.2%) | 28 (38.9%) | 25 (6.4%) | <0.001 |
| IDDM (%) | 7 (10.4%) | 12 (16.7%) | 38 (9.8%) | |
| (N)AFLD | 29 (43.3%) | 29 (40.3%) | 88 (22.7%) | 0.001 |
| Cholestatic LD | 0 (0.0%) | 1 (1.4%) | 9 (2.3%) | |
| Hepatitis C | 31 (46.3%) | 29 (40.3%) | 223 (57.5%) | |
| Hepatitis B | 0 (0.0%) | 5 (6.9%) | 12 (3.1%) | |
| Other LD | 7 (10.4%) | 8 (11.1%) | 56 (14.4%) | |
CAP = controlled attenuation parameters; BMI = body-mass index, NIDDM = non-insulin dependent diabetes mellitus; IDDM = insulin-dependent diabetes mellitus; LD = liver disease.